IPOs

Neos pulls off a $72M IPO to push its ADHD drugs forward
Fierce Biotech
Fri, 07/24/15 - 05:47 pm
Neos
IPOs
ADHD
Pint-sized biotechs join the IPO queue as Wall Street cash pours in
Fierce Biotech
Fri, 07/17/15 - 12:11 pm
IPOs
biotech
Intec Pharma
EyeGate Pharma
Neos angles for a $74M IPO to fund its ADHD drugs
Fierce Biotech
Mon, 07/13/15 - 11:44 am
Neos
ADHD
IPOs
Volatile Mixture: Young Biotechs' Stock Market Rollercoaster
Forbes
Fri, 07/10/15 - 12:34 pm
biotech
IPOs
startups
Gensight scouts a $100M IPO for its ocular gene therapies
Fierce Biotech
Wed, 07/8/15 - 11:35 am
Gensight Biologics
IPOs
ocular gene therapies
gene therapy
IPO Preview: Seres Therapeutics
Seeking Alpha
Wed, 07/1/15 - 04:04 pm
IPOs
Seres Therapeutics
microbiome
Samsung and Biogen plot an IPO for their biosimilars JV
Fierce Biotech
Tue, 06/30/15 - 11:32 am
Samsung
Biogen
IPOs
biosimilars
Samsung Bioepis
Glaukos Corp Completed Its IPO This Week; Now Trades Near $28 Mark
Yahoo/Benzinga
Sun, 06/28/15 - 11:35 am
Glaukos
IPOs
ophthalmic
glaucoma
Seres guts out a $134M IPO to fuel microbiome R&D
Fierce Biotech
Fri, 06/26/15 - 08:01 pm
Seres
microbiome
IPOs
R&D
Biotech's IPO boom flirts with new heights as dollars pour in
Fierce Biotech
Tue, 06/23/15 - 11:05 am
biotech
IPOs
Biotechs line up for a busy week of IPOs
Fierce Biotech
Mon, 06/22/15 - 11:17 am
biotech
IPOs
Seres Therapeutics
Glaukos
Pieris
Catabasis
Antibiotics biotech Nabriva shoots for a $92M IPO
Fierce Biotech
Fri, 06/19/15 - 10:07 am
Nabriva Therapeutics
IPOs
antibiotics
lefamulin
Fitbit raises $732m in IPO
Mass Device
Thu, 06/18/15 - 11:09 am
IPOs
devices
Fitbit
Cosmo to Seek More Than $107 Million in Dermatology Unit IPO
Bloomberg
Mon, 06/15/15 - 09:56 am
Cosmo Pharma
dermatology
IPOs
Dementia drug developer Axovant nearly doubles after IPO prices above estimates at $315M
Yahoo/AP
Fri, 06/12/15 - 09:29 am
Axovant
dementia
IPOs
The 29 Year Old Behind The Giant Biotech IPO That Rose By 90% Speaks
Forbes
Thu, 06/11/15 - 06:11 pm
biotech
IPOs
Axovant Sciences
Targovax to merge with Oncos then IPO in push for immuno-oncology mainstream
Fierce Biotech
Thu, 06/11/15 - 12:00 pm
Targovax
Oncos Therapeutics
immuno-oncology
IPOs
M&A
Abivax tees up a $49M IPO to get its hep B shot into Phase III
Fierce Biotech
Fri, 06/5/15 - 10:38 am
Abivax
IPOs
hepatitis B
vaccines
ABX203
Europe
Pioneering microbiome upstart Seres Therapeutics targets a $100M IPO
Fierce Biotech
Thu, 05/28/15 - 09:44 am
IPOs
Seres Therapeutics
Chinese biotech 3SBIO launches up to $712 million HK IPO: term sheet
Yahoo/Reuters
Wed, 05/27/15 - 09:23 am
3SBio
China
IPOs

Pages